Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
53.6M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
3.07M
-
Shares change
-
+1.49M
-
Total reported value, excl. options
-
$6.54M
-
Value change
-
+$3.16M
-
Number of buys
-
9
-
Number of sells
-
-8
-
Price
-
$2.14
Significant Holders of SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) as of Q1 2023
27 filings reported holding SLNO - SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share as of Q1 2023.
SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.07M shares
of 53.6M outstanding shares and own 5.73% of the company stock.
Largest 10 shareholders include Carlyle Group Inc. (1.2M shares), Nantahala Capital Management, LLC (699K shares), AIGH Capital Management LLC (422K shares), J. Goldman & Co LP (269K shares), Worth Venture Partners, LLC (104K shares), Clayton Partners LLC (92.8K shares), RENAISSANCE TECHNOLOGIES LLC (76.5K shares), JPMORGAN CHASE & CO (69.9K shares), VANGUARD GROUP INC (49.9K shares), and GEODE CAPITAL MANAGEMENT, LLC (32.6K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.